IL2 and COVID-19: Usually, patients who have COVID-19 have a decreased number of helper T cells, cytotoxic T cells, regulatory T cells, and natural killer (NK) cells, but increased leptin, TNF-α, interleukin-1 (IL-1), interleukin-2 (IL-2), and interferon-gamma (IFN-γ).